Donald Trump imposes 100% tariff on branded pharma imports, restructures metal duties

Apr 03, 2026

U.S. President Donald Trump has announced sweeping new tariffs, including up to 100% duty on patented drug imports from countries like India. While generic medicines are currently exempt, officials warn they could be included later. The move aims to push pharma companies to shift production to the U.S. and reduce foreign dependence. Selective tariff relief has been given to partners like the European Union, Japan, South Korea, and the UK. The U.S. has also revised tariffs on metals, adding a 25% duty on certain products.